GlassScriptPhysician profile
Sam Cohlmia
NPI 1780641878
$802.77
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $45.31 · 2022: $157 · 2023: $249 · 2024: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $274.65 | 2019-2024 | Clareon |
| Carl Zeiss Meditec USA, INC. | $156.64 | 2023 | |
| Allergan, INC. | $136.70 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $122.12 | 2024 | Syfovre |
| Bausch & Lomb Americas INC. | $22.28 | 2024 | Vyzulta, Miebo, Lotemax Sm |
| Sight Sciences, INC. | $21.74 | 2019 | |
| Glaukos Corporation | $20.93 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rxsight INC | $17.02 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Novartis Pharmaceuticals Corporation | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Cohlmia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.